{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:26:28Z","timestamp":1789500388331,"version":"build-2803163510"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,3,1]]},"DOI":"10.2169\/internalmedicine.2126-23","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:21:08Z","timestamp":1709245268000},"page":"699-705","source":"Crossref","is-referenced-by-count":7,"title":["Anti-contactin 1 Antibody-associated Membranous Nephropathy in Chronic Inflammatory Demyelinating Polyneuropathy with Several Autoantibodies"],"prefix":"10.2169","volume":"63","author":[{"given":"Ryutaro","family":"Shida","sequence":"first","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Iwakura","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naro","family":"Ohashi","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiemi","family":"Ema","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Aoki","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tashiro","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ishigaki","sequence":"additional","affiliation":[{"name":"Blood Purification Unit, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Isobe","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Fujikura","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kato","sequence":"additional","affiliation":[{"name":"Blood Purification Unit, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Fujigaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Analytic Human Pathology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasuda","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Division of Nephrology, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 82: 879-886, 2014.","DOI":"10.1212\/WNL.0000000000000205"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ogata H, Yamasaki R, Hiwatashi A, et al. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol 2: 960-971, 2015.","DOI":"10.1002\/acn3.248"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 73: 370-380, 2013.","DOI":"10.1002\/ana.23794"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Miura Y, Devaux JJ, Fukami Y, et al. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain 138: 1484-1491, 2015.","DOI":"10.1093\/brain\/awv054"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Doppler K, Appeltshauser L, Wilhelmi K, et al. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies. J Neurol Neurosurg Psychiatry 86: 720-728, 2015.","DOI":"10.1136\/jnnp-2014-309916"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Doppler K, Appeltshauser L, Villmann C, et al. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain 139: 2617-2630, 2016.","DOI":"10.1093\/brain\/aww189"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Vural A, Doppler K, Meinl E. Autoantibodies against the node of ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance. Front Immunol 9: 1029, 2018.","DOI":"10.3389\/fimmu.2018.01029"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Xu Q, Liu S, Zhang P, et al. Characteristics of anti-contactin1 antibody-associated autoimmune nodopathies with concomitant membranous nephropathy. Front Immunol 12: 759187, 2021.","DOI":"10.3389\/fimmu.2021.759187"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Le Quintrec M, Teisseyre M, Bec N, et al. Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy. Kidney Int 100: 1240-1249, 2021.","DOI":"10.1016\/j.kint.2021.08.014"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hashimoto Y, Ogata H, Yamasaki R, et al. Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey. Front Neurol 9: 997, 2018.","DOI":"10.3389\/fneur.2018.00997"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Santoro D, Debiec H, Longhitano E, et al. Contactin 1, a potential new antigen target in membranous nephropathy: a case report. Am J Kidney Dis 80: 289-294, 2022.","DOI":"10.1053\/j.ajkd.2021.08.025"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Plaisier E, Not A, Buob D, Ronco P, Debiec H. Contactin-1-associated membranous nephropathy: complete immunologic and clinical remission with rituximab. Kidney Int 100: 1342-1344, 2021.","DOI":"10.1016\/j.kint.2021.08.029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Taieb G, Le Quintrec M, Pialot A, et al.  "Neuro-renal syndrome" related to anti-contactin-1 antibodies. Muscle Nerve 59: E19-E21, 2019.","DOI":"10.1002\/mus.26392"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nazarali S, Mathey EK, Tang D, Margetts PJ, Baker SK. Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy. Can J Neurol Sci 47: 585-587, 2020.","DOI":"10.1017\/cjn.2020.46"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wang X, Xia Y. Anti-double stranded DNA antibodies: origin, pathogenicity, and targeted therapies. Front Immunol 10: 1667, 2019.","DOI":"10.3389\/fimmu.2019.01667"},{"key":"16","unstructured":"16. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71: 1400-1412, 2019."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pr\u00f6bstel AK, Thanei M, Erni B, et al. Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus. Rheumatology (Oxford) 58: 908-913, 2019.","DOI":"10.1093\/rheumatology\/key282"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Manolova I, Dancheva M, Halacheva K. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int 20: 197-204, 2001.","DOI":"10.1007\/s002960100108"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Li CH, Li YC, Xu PS, Hu X, Wang CY, Zou GL. Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis. Scand J Rheumatol 35: 201-208, 2006.","DOI":"10.1080\/03009740500303181"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Li H, Lan P, Yu X, et al. Analysis of the expression of exostosins and clinicopathological features in membranous lupus nephritis in a chinese cohort. Kidney Int Rep 7: 2295-2298, 2022.","DOI":"10.1016\/j.ekir.2022.07.164"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ravindran A, Casal Moura M, Fervenza FC, et al. In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes. J Am Soc Nephrol 32: 695-706, 2021.","DOI":"10.1681\/ASN.2020081181"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sethi S, Madden BJ, Debiec H, et al. Exostosin 1\/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30: 1123-1136, 2019.","DOI":"10.1681\/ASN.2018080852"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ronco P, Plaisier E, Debiec H. Advances in membranous nephropathy. J Clin Med 10: 2021.","DOI":"10.3390\/jcm10040607"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol 24: 1357-1366, 2013.","DOI":"10.1681\/ASN.2013010026"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/5\/63_2126-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T03:38:48Z","timestamp":1709350728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/5\/63_2126-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2126-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"article-number":"2126-23"}}